High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents

Clinical Cancer Research

Volumn 12, Issue 8, 2006, Pages 2455-2462

  Matsumoto, Ken Ichiro ^a   Hyodo, Fuminori ^a   Matsumoto, Atsuko ^a   Koretsky, Alan P ^b   Sowers, Anastasia L ^a   Mitchell, James B ^a   Krishna, Murali C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CARBAMOYL 2,2,5,5 TETRAMETHYLPYRROLIDINE 1 OXYL; CONTRAST MEDIUM; HYDROXYLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ELECTRON SPIN RESONANCE; FEMALE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RADIOISOTOPE DECAY; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CYCLIC N-OXIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C3H; MODELS, CHEMICAL; MUSCLES; NEOPLASMS, EXPERIMENTAL; NITROGEN OXIDES; OXIDATION-REDUCTION; PYRROLIDINES;

EID: 33646394317     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2747     Document Type: Article

References (42)

1. Dunn JF, O'Hara JA, Zaim-Wadghiri Y, et al. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J Magn Reson Imaging 2002;16:511-21.
2. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 2004;101:10901-6.
3. Brasch RC, Nitecki DE, Brant-Zawadzki M, et al. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. AJR Am J Roentgenol 1983;141:1019-23.
4. Brasch RC, London DA, Wesbey GE, et al. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 1983;147:773-9.
5. Brasch RC. Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. Radiology 1983;147:781-8.
6. Berliner LJ, Fujii H, Wan XM, Lukiewicz SJ. Feasibility study of imaging a living murine tumor by electron paramagnetic resonance. Magn Reson Med 1987;4:380-4.
7. Keana JF, Pou S. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the "reduction problem" of nitroxides as MRI contrast agents. Physiol Chem Phys Med NMR 1985;17:235-40.
8. Chen K, Glockner JF, Morse PD II, Swartz HM. Effects of oxygen on the metabolism of nitroxide spin labels in cells. Biochemistry 1989;28:2496-501.
9. Keana JF, Pou S, Rosen GM. Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Magn Reson Med 1987;5:525-36.
10. Swartz HM, Sentjurc M, Morse PD II. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim Biophys Acta 1986;888:82-90.
11. Sentjurc M, Pecar S, Chen K, Wu M, Swartz H. Cellular metabolism of proxyl nitroxides and hydroxylamines. Biochim Biophys Acta 1991;1073:329-35.
12. Krishna MC, Grahame DA, Samuni A, Mitchell JB, Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A 1992;89:5537-41.
13. Krishna MC, Russo A, Mitchell JB, Goldstein S, Dafni H, Samuni A. Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem 1996;271:26026-31.
14. Krishna MC, Samuni A, Taira J, Goldstein S, Mitchell JB, Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem 1996;271:26018-25.
15. Krishna MC, DeGraff W, Hankovszky OH, et al. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J Med Chem 1998;41:3477-92.
16. Ilangovan G, Li H, Zweier JL, Krishna MC, Mitchell JB, Kuppusamy P. In vivo measurement of regional oxygenation and imaging of redox status in RIF-1 murine tumor: effect of carbogen-breathing. Magn Reson Med 2002;48:723-30.
17. Kuppusamy P, Afeworki M, Shankar RA, et al. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res 1998;58:1562-8.
18. Kuppusamy P, Li H, Ilangovan G, et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 2002;62:307-12.
19. Yamada K, Kuppusamy P, English S, et al. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol 2002;43:433-40.
20. Utsumi H, Yamada K. In vivo electron spin resonance-computed tomography/nitroxyl probe technique for non-invasive analysis of oxidative injuries. Arch Biochem Biophys 2003;416:1-8.
21. Samuni A, Goldstein S, Russo A, Mitchell JB, Krishna MC, Neta P. Kinetics and mechanism of hydroxyl radical and OH-adduct radical reactions with nitroxides and with their hydroxylamines. J Am Chem Soc 2002;124:8719-24.
22. Takeshita K, Saito K, Ueda J, Anzai K, Ozawa T. Kinetic study on ESR signal decay of nitroxyl radicals, potent redox probes for in vivo ESR spectroscopy, caused by reactive oxygen species. Biochim Biophys Acta 2002;1573:156-64.
23. Ui I, Okajo A, Endo K, Utsumi H, Matsumoto K. Effect of hydrogen peroxide in redox status estimation using nitroxyl spin probe. Free Radic Biol Med 2004;37:2012-7.
24. Utsumi H, Takeshita K, Ichikawa K, et al. In vivo ESR measurements of free radical reactions in living mice. J Toxicol Sci 1996;21:293-5.
25. Swartz HM, Chen K, Pals M, Sentjurc M, Morse PD II. Hypoxia-sensitive NMR contrast agents Magn Reson Med 1986;3:169-74.
26. Krishna MC, Samuni A. Nitroxides as antioxidants. Methods Enzymol 1994;234:580-9.
27. Doty FD, Entzminger G, Jr., Hauck CD. Error-tolerant RF litz coils for NMR/MRI. J Magn Reson 1999;140:17-31.
28. Koscielniak J, Devasahayam N, Moni MS, et al. 300 MHz continuous wave electron paramgnetic resonace spectrometer for small animal in vivo imaging. Rev Sci Instrum 2000;71:4273-81.
29. Hahn SM, DeLuca AM, Coffin D, Krishna CM, Mitchell JB. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Int J Radiat Oncol Biol Phys 1998;42:839-42.
30. Samuni AM, Chuang EY, Krishna MC, et al. Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants. Proc Natl Acad Sci U S A 2003;100:5390-5.
31. Mitchell JB, Russo A, Kuppusamy P, Krishna MC. Radiation, radicals, and images. Ann N Y Acad Sci 2000;899:28-43.
32. Suy S, Mitchell JB, Ehleiter D, Haimovitz-Friedman A, Kasid U. Nitroxides tempol and tempo induce divergent signal transduction pathways in MDA-MB 231 breast cancer cells. J Biol Chem 1998;273:17871-8.
33. Gariboldi MB, Rimoldi V, Supino R, Favini E, Monti E. The nitroxide tempol induces oxidative stress, p21 (WAF1/CIP1), and cell death in HL60 cells. Free Radic Biol Med 2000;29:633-41.
34. Gariboldi MB, Lucchi S, Caserini C, Supino R, Oliva C, Monti E. Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines. Free Radic Biol Med 1998;24:913-23.
35. Mitchell JB, Xavier S, DeLuca AM, et al. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med 2003;34:93-102.
36. Hahn SM, Tochner Z, Krishna CM, et al. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res 1992;52:1750-3.
37. Hahn SM, Sullivan FJ, DeLuca AM, et al. Evaluation of tempol radioprotection in a murine tumor model. Free Radic Biol Med 1997;22:1211-6.
38. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-212.
39. Mitchell JB, Krishna MC, Kuppusamy P, Cook JA, Russo A. Protection against oxidative stress by nitroxides. Exp Biol Med (Maywood) 2001;226:620-1.
40. Metz JM, Smith D, Mick R, et al. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res 2004;10:6411-7.
41. Fujii H, Wan X, Zhong J, Berliner LJ, Yoshikawa K. In vivo imaging of spin-trapped nitric oxide in rats with septic shock: MRI spin trapping. Magn Reson Med 1999;42:235-9.
42. Demsar F, Kveder M, Ruglej S, Blinc A, Sentjurc M, Pecar S. Hydroxylamines as oxygen-sensitive procontrast agents for in vivo magnetic resonance imaging. J Magn Reson 1991;95:281-5.